Gian Matteo Rigolin

Comparison of Two Different Therapeutic Regimens with Azacitidine and Lenalidomide (Combined versus Sequential) in Higher-Risk Myelodysplastic Syndromes. Update of Long-Term Results of a Randomized Phase II Multicenter Study

Michele Cavo, Patrizia Tosi, Marco Gobbi, 2018, Blood.

Azacitidine and Lenalidomide (Combined vs Sequential Treatment) in Higher-Risk Myelodysplastic Syndromes. Long-Term Results of a Randomized Phase II Multicenter Study

Michele Cavo, Patrizia Tosi, Marco Gobbi, 2016 .

BIRC3 disruption and Copy Number Aberrations in Chronic Lymphocytic Leukemia (CLL) Patients with 11q Deletion

Robin Foà, Davide Rossi, Sabina Chiaretti, 2014 .